Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Surgical Oncology
Erschienen in: Indian Journal of Surgical Oncology 1/2023

18.08.2022 | Review Article

ERCC2 rs13181 Polymorphism Association with Glioma Risk: an Update Meta-Analysis

verfasst von: Nader Salari, Shna Rasoulpoor, Shervin Shabani, Kamran Mansouri, Shadi Bokaee, Reza Fatahian, Negin Farshchian, Masoud Mohammadi, Melika Hosseinian-Far

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Glioma is the most common type of primary brain tumour which accounts for about 30% of all brain and central nervous system tumours, and approximately 70% of adult malignant brain tumours. Numerous studies have been performed to assess the relationship between ERCC2 rs13181 polymorphism and the risk of glioma development, yet these findings of these studies are often inconsistent and contradictory. Therefore, the aim of this study is to conduct a systematic review and meta-analysis to assess the role of ERCC2 rs13181 in glioma developing. In this work, we have conducted a systematic review and meta-analysis. In order to collect the results of relevant studies on the association of ERCC2 rs13181 gene polymorphism with glioma, we initially searched the Scopus, Embase, Web of Science (WoS), PubMed, and ScienceDirect databases, without a lower time limit, and until June 2020. In order to analyse the eligible studies, the random effects model was used and the heterogeneity of the studies was investigated with the I2 index. Data analysis was performed within the Comprehensive Meta-Analysis software (version 2). The total number of studies that focused on patients with glioma was 10. The odds ratio of GG vs TT genotype in patients with glioma based on meta-analysis was 1.08 (0.85–1.37: 95% confidence interval), which indicates the increasing effect of GG vs TT genotype by 0.08. The odds ratio of GG + TG vs TT genotype in patients with glioma was 1.22 (1.38–1.7: 95% confidence interval) based on meta-analysis, which indicates the increasing effect of GG + TG vs TT genotype as 0.22. The odds ratio of TG vs TT genotype in patients with glioma was 1.2 (0.38–1.4: 95% confidence interval), which shows the increasing effect of TG vs TT genotype by 0.2. The odds ratio of G vs T genotype in patients with glioma based on the meta-analysis was 1.15 (1.26–1.4: 95% confidence interval), which indicates the increasing effect of G vs T genotype by 0.15. The odds ratio of GG vs TG + TT genotype in patients with glioma based on meta-analysis was 1.22 (1.33–1.45: 95% confidence interval), which indicates the increasing effect of GG vs TG + TT genotype by 0.22. The results of this systematic review and meta-analysis show that ERCC2 rs13181 polymorphism and its genotypes are an important risk factor for genetic susceptibility to glioma tumour.
Literatur
1.
Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y (2012) Primary brain tumours in adults. Lancet 379(9830):1984–1996PubMedCrossRef
2.
Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820PubMedCrossRef
3.
4.
5.
6.
Brenner A, Butler M, Wang S, Ruder A, Rothman N, Schulte P et al (2007) Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 28(12):2543–2547PubMedCrossRef
7.
Bethke L, Sullivan K, Webb E, Murray A, Schoemaker M, Auvinen A et al (2008) The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Prev Biomarkers 17(4):987–989CrossRef
8.
Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, Kelsey KT et al (2007) DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29(1–2):55–58PubMedCrossRef
9.
Pinto G, Yoshioka F, Silva R, Clara C, Santos M, Almeida J et al (2008) Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet Mol Res 7(1):207–216PubMedCrossRef
10.
11.
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93–108PubMedCrossRef
12.
Wen PY, Kesari S (2008) Malignant gliomas in adults-Reply. N Engl J Med 359(17):1850CrossRef
13.
Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9):494–503PubMedCrossRef
14.
Dong Y-S, Hou W-G, Li X-L, Jin T-B, Li Y, Feng D-Y et al (2014) Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population. Tumor Biol 35(5):4937–4941CrossRef
15.
Wei X-B, Jin T-B, Li G, Geng T-T, Zhang J-Y, Chen C-P et al (2014) CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population. Asian Pac J Cancer Prev 15(8):3629–3633PubMedCrossRef
16.
Zhu W, Lu L, Li Y, Yao J, Xu B (2014) The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis. Tumor Biol 35(4):3725–3730CrossRef
17.
Pacini F, Castagna M, Brilli L, Pentheroudakis G, Group EGW (2012) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(suppl_7):vii110–vii9PubMedCrossRef
18.
Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789–799PubMedCrossRef
19.
Zhang J, Gu S-Y, Zhang P, Jia Z, Chang J-H (2010) ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians. Eur J Cancer 46(13):2479–2484PubMedCrossRef
20.
Xue H, Lu Y, Lin B, Chen J, Tang F, Huang G (2012) The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS ONE 7(9):e43431PubMedPubMedCentralCrossRef
21.
Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L et al (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25(12):2433–2441PubMedCrossRef
22.
Juenger CH, Holst MI, Duffe K, Jankowski J, Baader SL (2005) Tetraspanin-5 (Tm4sf9) mRNA expression parallels neuronal maturation in the cerebellum of normal and L7En-2 transgenic mice. J Comp Neurol 483(3):318–328PubMedCrossRef
23.
Neumann AS, Sturgis EM, Wei Q (2005) Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 42(2):65–92PubMedCrossRef
24.
McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P et al (2009) Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Prev Biomarkers 18(4):1118–1126CrossRef
25.
Huang L-M, Shi X, Yan D-F, Zheng M, Deng Y-J, Zeng W-C et al (2014) Association between ERCC2 polymorphisms and glioma risk: a meta-analysis. Asian Pac J Cancer Prev 15(11):4417–4422PubMedCrossRef
26.
Xin Y, Hao S, Lu J, Wang Q, Zhang L (2014) Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis. PloS one 9(4):e95966PubMedPubMedCentralCrossRef
27.
Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M (2014) Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncol 16(6):807–814PubMedPubMedCentralCrossRef
28.
Gao K, Mu S, Wu Z (2014) Investigation of the effects of single-nucleotide polymorphisms in DNA repair genes on the risk of glioma. Genet Mol Res 13(1):1203–1211PubMedCrossRef
29.
Rodriguez-Hernandez I, Perdomo S, Santos-Briz A, Garcia JL, Gomez-Moreta JA, Cruz JJ et al (2014) Analysis of DNA repair gene polymorphisms in glioblastoma. Gene 536(1):79–83PubMedCrossRef
30.
Jia T, Wu H, Wang H, Ma W, Xing B (2015) Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis. Genet Mol Res 14(4):12577–12584PubMedCrossRef
31.
Salari N, Mohammadi M, Vaisi-Raygani A, Abdi A, Shohaimi S, Khaledipaveh B et al (2020) The prevalence of severe depression in Iranian older adult: a meta-analysis and meta-regression. BMC Geriatr 20(1):39PubMedPubMedCentralCrossRef
32.
Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Prev Biomarkers 11(12):1513–1530
33.
Yan Y, Liang H, Light M, Li T, Deng Y, Li M et al (2014) XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis. Tumor Biol 35(3):1907–15CrossRef
34.
Liu D, Wu D, Li H, Dong M (2014) The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis. Gene 538(2):209–216PubMedCrossRef
35.
Guo X-F, Wang J, Lei X-F, Zeng Y-P, Dong W-G (2015) XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis. Intern Med 54(3):251–259PubMedCrossRef
36.
Yang Q, Wei YF, Zhang Y, Huang GH (2015) XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population. Exp Ther Med 9(6):2406–2414PubMedPubMedCentralCrossRef
37.
Caggana M, Kilgallen J, Conroy JM, Wiencke JK, Kelsey KT, Miike R et al (2001) Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Prev Biomarkers 10(4):355–360
38.
Liu Y, Scheurer ME, El-Zein R, Cao Y, Do K-A, Gilbert M et al (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Prev Biomarkers 18(1):204–214CrossRef
39.
Hui L, Yue S, Gao G, Chang H, Li X (2014) Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk. Tumor Biology 35(8):7451–7457PubMedCrossRef
40.
Luo K-Q, Mu S-Q, Wu Z-X, Shi Y-N, Peng J-C (2013) Polymorphisms in DNA repair genes and risk of glioma and meningioma. Asian Pac J Cancer Prev 14(1):449–452PubMedCrossRef
41.
Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Sison JD et al (2005) ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol 7(4):495–507PubMedPubMedCentralCrossRef
42.
Qian T, Zhang B, Qian C, He Y, Li Y (2017) Association between common polymorphisms in ERCC gene and glioma risk: a meta-analysis of 15 studies. Medicine 96(20):e6832PubMedPubMedCentralCrossRef
43.
Tavares CB, Gomes-Braga FdCSA, Sousa EB, Brito JNPdO, Melo MdA, Campelo V et al (2020) Association between single nucleotide polymorphisms and glioma risk: a systematic literature review. Cancer Invest 38(3):169–183PubMedCrossRef
44.
Chen D-Q, Yao D-X, Zhao H-Y, Yang S-J (2012) DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis. Asian Pac J Cancer Prev 13(6):2791–2794PubMedCrossRef
45.
Qi L, Yu H-q, Zhang Y, Ding L-j, Zhao D-h, Lv P et al (2017) A comprehensive meta-analysis of genetic associations between key polymorphic loci in DNA repair genes and glioma risk. Mol Neurobiol 54(2):1314–1325PubMedCrossRef
46.
Al-Khatib SM, Abdo N, Al-Eitan LN, Al-Mistarehi A-HW, Zahran DJ, Al Ajlouni M et al (2020) The impact of the genetic polymorphism in DNA repair pathways on increased risk of glioblastoma multiforme in the Arab Jordanian population: a case–control study. Appl Clin Genet 13:115–126PubMedPubMedCentralCrossRef
Metadaten
Titel
ERCC2 rs13181 Polymorphism Association with Glioma Risk: an Update Meta-Analysis
verfasst von
Nader Salari
Shna Rasoulpoor
Shervin Shabani
Kamran Mansouri
Shadi Bokaee
Reza Fatahian
Negin Farshchian
Masoud Mohammadi
Melika Hosseinian-Far
Publikationsdatum
18.08.2022
Verlag
Springer India
Erschienen in
Indian Journal of Surgical Oncology / Ausgabe 1/2023
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-022-01623-6

Weitere Artikel der Ausgabe 1/2023

Indian Journal of Surgical Oncology 1/2023 Zur Ausgabe

Letter to the Editor

Cellular Fibroma Ovary with Minor Sex Cord Elements Associated with Endometrial Adenocarcinoma: a Rare Entity

Original Article

To CT or not to CT: Questioning the Cost-Effectiveness of CT Thorax in Head and Neck Cancers

Original Article

Breast Conservative Surgery for Breast Cancer: Indian Surgeon’s Preferences and Factors Influencing Them

Original Article

Clinicopathologic Correlation of CD44 + /CD24 − Expression in Breast Cancer: a Report from Tertiary Care Medical University in India

Original Article

Malignant Adenomyoepithelial Tumour of the Breast — a Rare Diagnosis — Case Report

Correction

Correction to: Robot-Assisted Esophagectomy After Neoadjuvant Chemoradiation—Current Status and Future Prospects

Neu im Fachgebiet Chirurgie

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik

09.04.2024 | Appendektomie | Nachrichten

Appendektomie: Vorsicht bei systemischen Glukokortikoiden!
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.